The treatment is monoclonal antibody therapy, and the antibodies come from people who have recovered from the novel coronavirus. To develop a monoclonal antibody treatment, researchers cull through thousands of antibodies to find the best ones, and then clone them potentially in unlimited amounts. The lead scientist in Rockefeller's monoclonal antibody effort compares it to battle, noting that convalescent plasma has been used for more than a century. The company already makes monoclonal antibodies for several illnesses, including cancer, arthritis and asthma. He said it's a good sign that several teams are working on monoclonal antibodies.

Source: CNN May 06, 2020 18:00 UTC